GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
2.795
-0.301 (-9.72%)
At close: Jul 3, 2025, 1:00 PM
2.760
-0.035 (-1.25%)
After-hours: Jul 3, 2025, 4:40 PM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $8.80 million as of July 3, 2025. Its market cap has increased by 39.72% in one year.
Market Cap
8.80M
Enterprise Value
6.43M
1-Year Change
39.72%
Ranking
Category
Stock Price
$2.80
Market Cap Chart
Since October 18, 1983, GT Biopharma's market cap has decreased from $937.50M to $8.80M, a decrease of -99.06%. That is a compound annual growth rate of -10.58%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 306.47B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 238.56B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 216.08B |